Fluicell, Mölndal. 54 likes. Founded in 2012, Fluicell is a public biotech company providing platforms to investigate cell behavior like never before. Fluicell develops and provides high precision

2629

2021-04-12

fluicell: styrelseledamot sÅlt aktier pga bosatt i usa: 19-11-2020: fluicell: lÄgre oms 3 kv men fÖrsÄljning har tagit fart enl vd: 30-10-2020: fluicell: erhÅller eu-anslag om 5,2 mln kr : 16-10-2020: fluicell: gÖr riktad emission, teckningskurs 7:60 kr/aktie: 30-09-2020: fluicell: order frÅn tyskt universitet, vÄrde 14.000 eur : 15-06-2020 Fluicell är ett teknikbolag. Specialisering sker inom bearbetning och studering av cellers sammansättning vid läkemedelsutvecklingar. Bolaget har framtagit en produktportfölj bestående av patenterade forskningsinstrument, som används för att studera, analysera och slutligen bearbeta celler. Fluicell made its first sale in March of 2020 to the University of Canterbury in New Zealand. Since then, Fluicell has kicked off its own contract research organisation (CRO) services. For now, these services are mainly run through Biopixlar, which, on its own, addresses a mass market of about 1.3 BUSD with an expected annual growth between 17 and 26 per cent.

Fluicell news

  1. Olovlig franvaro loneavdrag
  2. Ekonomiskt bistånd tandvård
  3. Stora coop stadion

Get Fluicell AB (5J9-FF:Frankfurt Stock Exchange) real-time stock quotes, news, price and financial information from CNBC. Fluicell AB | 1476 followers on LinkedIn. Based in Gothenburg Sweden, Fluicell is an innovative life science company View all updates, news, and articles. Fluicell is one of the manufacturers of fluid platforms for multifunctional pipettes. Recent News & Activity. Details.

112 likes.

Delayed Quote. Delayed - 03/23 12:29:46 pm. 29.9SEK, -12.06%. 5d 

Microfluidics News and Research. RSS AXT offer Fluicell's innovative range of tissue engineering systems in Australia & NZ. AXT are proud to announce that  Manufacturer, 3DCultures, CellInk, CellInk, CellInk, FELIX printer, Allevi, Allevi, Allevi, Brinter, CellInk, Fluicell, Advanced Solutions, Cyfuse, Poietis. The BIOPEN® systems, developed by Fluicell, are unique and powerful microfluidic devices for maintaining localized drug delivery in single-cell experiments,  Dec 12, 2019 3D printing news Interview with Gavin Jeffries from Fluicell: "Cell Biology is at the Core of our A Swedish company called Fluicell is out to change the reigning trend and has just released a new system for c Feb 10, 2021 10x genomics; Becton Dickinson (BD); Berkeley lights; Bio-rad; Carl Zeiss; Celsee; Dolomite bio; Eppendorf; Fluicell; Fluidigm; iBiochips  Nov 5, 2019 Based on innovative Fluicell technology, Biopixlar is capable of generating detailed, multi-cellular biological tissues, directly in native cell  Events & News · MAWORDE(Made in China) · Baker Ruskinn workstations · Fluicell · Imaging system in worktation or incubator · Myostation · Noxygen. Dec 22, 2020 H2020,BIRDIE,FETOPEN-01-2018-2019-2020,UNIVERSITEIT MAASTRICHT(NL ),FLUICELL AB(SE),UNIVERSITE DE NANTES(FR),TISSUSE  News agencies, without understanding the essence of the message, spread the Fluicell, a Swedish biotech company, specializes in development of platforms  Tatsiana LOBOVKINA, CSO | Cited by 1777 | of Fluicell, Göteborg | Read 33 publications | Contact Tatsiana LOBOVKINA.

Fluicell news

Fluicell AB (publ) ("Fluicell" eller "Bolaget") meddelar härmed att https://news.cision.com/se/fluicell/r/fluicell-mottar-koporder-pa-dynafl.

Fluicell news

Fluicell is an innovative life science company dedicated to providing single-cell microfluidic research tools and services for scientists worldwide. We deliver easy-to-use solutions for your research needs in single-cell biology, electrophysiology, single-cell bioprinting and tissue modelling.

Den första generationen instrument utvecklades samma år och bolaget har idag tolv patent som är godkända både i Europa och USA. Fluicell har sitt huvudkontor i Göteborg, omkring 30 kunder globalt samt 11 anställda. Fluicell launches Biozone 6.
Rederiet kaptaner

Fluicell news

Today, we would like to extend our warmest season’s greeting and wish for all of you a happy and safe 2021. Fluicell AB (publ.) (”Fluicell” eller ”Bolaget”) meddelar härmed att det tidigare kommunicerade forskningsprojekt som erhållit EU-anslag om totalt 3 miljoner EUR nu har inletts.

Försäljningen  Fluicell, 21-02-24 09:24 https://news.cision.com/se/saltx-technology-holding-ab/r/saltx-ingar-partnerskap-for-att-skala-upp-och-optimera-sin-laddningsreaktor,  miljarder kronor · Flygjättens underleverantör vädjar till långivarna · Kina: Exportförbud mot Ericsson är ”fake news” · Fiberoptikbolag köper amerikanskt bolag  #fluicell #iapotek #peptonicme #lidds går ok idag. 1. 0. 0.
Lena näslund linköping







miljarder kronor · Flygjättens underleverantör vädjar till långivarna · Kina: Exportförbud mot Ericsson är ”fake news” · Fiberoptikbolag köper amerikanskt bolag 

This much was clear in the Q1 report released by the Swedish single-cell technology company two weeks ago. The sales numbers are indicative of a strong first quarter for Fluicell with further expansion on the horizon, mainly thanks to the broad range of innovative products that the company already has on the market and its newly established CRO We are very excited to announce that Fluicell will be releasing its next product, Biozone 6™, during Q1 2021. Biozone 6™ is a new concept in high-resolution single-cell pharmacology. The product has been developed in connection with Hoffmann-La Roche and has been tailored to meet the demand for research tools for single-cell pharmacology. Fluicell recently announced that its first Biopixlar unit has been sold to the University of Canterbury in New Zealand, thus taking the first big step into the bioprinting market.

Welcome to the Fluicell AB Investor Relations page. On this page you can find annual reports, news, and other information regarding Fluicell. Collage of 5 

Details.

The product has been developed in connection with Hoffmann-La Roche and has been tailored to meet the demand for research tools for single-cell pharmacology. Fluicell recently announced that its first Biopixlar unit has been sold to the University of Canterbury in New Zealand, thus taking the first big step into the bioprinting market. The sale coincides with the start of a new collaboration between Fluicell and the university, which has agreed to … Welcome to the Fluicell AB Investor Relations page. On this page you can find annual reports, news, and other information regarding Fluicell. Press Releases Documents Financial Calendar FAQ Management and Board Company Presentation Share Owners Certified Adviser Fluicell, a biotech company located in Mölndal, has been leading in the field since 2012 when it came out with its first product, BioPen, a tool designed for single-cell manipulation.